[IKT] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
14-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -44.34%
YoY- -24.53%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 0 0 80 116 65 123 0 -
PBT -4,650 -4,178 -4,595 -5,778 -4,478 -4,279 -4,495 2.28%
Tax 0 0 46 37 -474 -112 0 -
NP -4,650 -4,178 -4,595 -5,778 -4,003 -4,167 -4,495 2.28%
Tax Rate - - - - - - - -
Total Cost 4,650 4,178 4,675 5,894 4,068 4,291 4,495 2.28%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 0.00 -417,794,000.00 -5,775.11 -4,963.46 -6,204.86 -3,375.91 0.00 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.73 -0.68 -0.86 -1.11 -0.87 -0.99 -1.06 -21.99%
EPS Diluted -0.73 -0.68 -0.86 -1.11 -0.87 -0.99 -1.06 -21.99%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.